Supply of Fibrinogen Concentrate Across Queensland Health

Objective To describe fibrinogen concentrate (FC) supply across Queensland Health. Methods Statewide FC supply from January 2016 to September 2026 was analysed by service type, geography, major trauma designation, viscoelastic haemostatic assay (VHA) availability and temporal trends. Results Of 24,717 g FC supplied, 97.0% was distributed to 54 hospitals, 2.0% to retrieval services and 1.0% to ambulance services. Of hospital supply, 25.4% reached regional and 6.1% remote/very remote hospitals; 66.2% was supplied to major trauma services and 92.9% to VHA‐capable hospitals. Population‐adjusted FC supply increased from 8.19 to 59.2 g per 100,000 population between 2016 and 2025. Conclusion FC supply has increased substantially across Queensland, extending to regional, remote and prehospital services. This highlights the value of statewide patient‐level utilisation data for haemovigilance.